Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings 0 21.05.2024 03:01 MarketWatch.com Hims & Hers Health’s stock jumped nearly 30% Monday after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
